Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medinotec (MDNC) Shares Outstanding (Weighted Average) (2022 - 2025)

Medinotec's Shares Outstanding (Weighted Average) history spans 4 years, with the latest figure at $11.8 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) changed 0.19% year-over-year to $11.8 million; the TTM value through Nov 2025 reached $11.8 million, changed 0.19%, while the annual FY2025 figure was $11.7 million, 0.0% changed from the prior year.
  • Shares Outstanding (Weighted Average) reached $11.8 million in Q4 2025 per MDNC's latest filing, roughly flat from $11.8 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $11.8 million in Q3 2025 to a low of $10.0 million in Q1 2022.
  • Average Shares Outstanding (Weighted Average) over 4 years is $11.6 million, with a median of $11.7 million recorded in 2022.
  • The largest YoY upside for Shares Outstanding (Weighted Average) was 17.34% in 2023 against a maximum downside of 0.0% in 2023.
  • A 4-year view of Shares Outstanding (Weighted Average) shows it stood at $11.7 million in 2022, then changed by 0.0% to $11.7 million in 2023, then changed by 0.0% to $11.7 million in 2024, then rose by 0.19% to $11.8 million in 2025.
  • Per Business Quant, the three most recent readings for MDNC's Shares Outstanding (Weighted Average) are $11.8 million (Q4 2025), $11.8 million (Q3 2025), and $11.7 million (Q2 2025).